Se espera que el mercado global de biomateriales crezca a una tasa anual compuesta del 12,6 % entre 2020 y 2029. Se espera que alcance más de 355 850 millones de dólares en 2029 desde los 122 300 millones de dólares en 2020.
Los biomateriales son materiales artificiales, sintéticos o naturales, que se utilizan en la tecnología médica para restaurar tejidos, huesos y órganos dañados a su funcionalidad original. Los implantes y aparatos médicos que reemplazan o complementan las funciones naturales del cuerpo utilizan estos componentes biológicos. El cuerpo no permite que ningún material extraño incremente totalmente sus operaciones biológicas; por lo tanto, los biomateriales implantables están diseñados para disminuir la reacción inmunológica negativa manteniendo al mismo tiempo un rendimiento adecuado. Estos biomateriales interactúan con los sistemas biológicos para lograr objetivos médicos como el tratamiento de afecciones cardiovasculares, dentales, ortopédicas y neurológicas.
La producción de dispositivos médicos se ha visto transformada por los biomateriales. Estas sustancias son flexibles, fáciles de fabricar, altamente biocompatibles, inertes y muy potentes. El desarrollo de biomateriales para implantes y regeneración ha aumentado la tasa de éxito de los implantes. Se emplean en una variedad de procedimientos, incluidos reemplazos de articulaciones, placas óseas, cemento óseo, ligamentos y tendones artificiales, implantes dentales para la fijación de dientes , prótesis de vasos sanguíneos, válvulas cardíacas, tejido artificial, lentes de contacto e implantes mamarios, todos los cuales apoyan la expansión del mercado.
Para garantizar su eficacia y calidad, los dispositivos basados en biomateriales deben pasar por un riguroso proceso clínico y regulatorio. La mayoría de los dispositivos basados en biomateriales son implantables, lo que constituye la principal causa de ello. Como resultado, antes de recibir la aprobación para su comercialización, deben pasar por una serie de procesos clínicos y regulatorios que son intrincados, dependen de la composición y están limitados. Como resultado, los participantes del mercado se muestran reacios a invertir en este mercado. Estas son las variables que se prevé que impidan la expansión del mercado durante el período de pronóstico.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD), (Miles de unidades) |
| Segmentación | Por tipo, aplicación y región. |
| Por tipo |
|
| Por aplicación |
|
| Por región |
|
Los gobiernos de los países subdesarrollados y en desarrollo financian la investigación en el campo de los biomateriales. Estos países tienen una atención sanitaria deficiente y esto ofrece una gran oportunidad, ya que se prevé que la necesidad de servicios sanitarios avanzados y equipos médicos novedosos en los respectivos sistemas sanitarios de estas naciones se verá impulsada por razones como el aumento de la población geriátrica, la creciente incidencia de enfermedades específicas y la creciente demanda de procedimientos quirúrgicos. En los próximos años, se prevé que esto presente a los participantes del mercado de los biomateriales perspectivas de crecimiento.
Los flujos de trabajo en la industria de la salud en todo el mundo se han visto obstaculizados por el COVID-19. Numerosas industrias, incluidas partes de la industria de la salud, se han visto obligadas a cerrar temporalmente debido a la enfermedad. Debido a la recesión económica mundial provocada por el COVID-19, los ingresos del mercado mundial de biomateriales también disminuyeron. La pandemia de COVID-19 tuvo una influencia significativa en el funcionamiento del tratamiento hospitalario general para pacientes que no tenían la infección por COVID-19 en hospitales de todo el mundo. Se prevé que el mercado de implantes ortopédicos se silencie a corto plazo como resultado de los cierres que impidieron la apertura de muchos hospitales y clínicas, lo que también reduce la necesidad de biomaterial. Sin embargo, con el aumento de la I+D para pruebas rápidas de detección de COVID-19 que emplean nanopartículas de oro, que se prevé que impulse el crecimiento del mercado, se prevé que la industria se recupere en los próximos uno o dos años.
The global Biomaterials Market is expected to grow at 12.6% CAGR from 2020 to 2029. It is expected to reach above USD 355.85 Billion by 2029 from USD 122.30 Billion in 2020.
North America held more than 42% of the Biomaterials Market revenue share in 2020 and will witness tremendous expansion during the forecast period.
The production of medical devices has been transformed by biomaterials. These substances are supple, simple to manufacture, highly biocompatible, inert, and very powerful. The development of biomaterials for implants and regeneration has increased the success rate of implants. They are employed in a variety of procedures, including joint replacements, bone plates, bone cement, artificial ligaments and tendons, dental implants for tooth fixation, blood vessel prostheses, heart valves, artificial tissue, contact lenses, and breast implants, all of which support the market's expansion.
The Biomaterials Market key players include Koninklijke DSM N.V., Corbion N.V., EPTAM Plastics, Ltd., DiSanto Technology, Inc., CoorsTek Medical LLC, Carpenter Technology Corporation, Zapp AG, United Titanium, Inc., Celanese Corporation, Victrex Plc, BASF SE, Evonik Industries AG,
The Health Care sector is major sector where the application of Biomaterials has seen more.
The Markets largest share is in the North America region.
The biomaterials market is segmented by type and by applications. In type segmentation can be further divided into metallic, polymeric, ceramic, and natural. The ageing population's impact on the frequency and prevalence of chronic diseases as well as patients' desire to retain their current level of activity and quality of life have all contributed to a substantial increase in the usage of implants over the past few years. The need for high-performance implantable biomaterials that can handle special challenges in cardiology, vascular therapy, orthopedics, trauma, spine, dental, and wound care has consequently been constantly growing. The excellent electrical, thermal, and mechanical properties of metals make them suitable as biomaterials. Furthermore, the accessibility of bioactive ceramics like hydroxyapatite has increased the bone's conductivity. Thus, the patient's quality of life has recently been greatly enhanced by the widespread use of metals in numerous applications. Making metallic type biomaterial most used type of biomaterials.
Based on application there are cardiovascular, dental, orthopedic, wound healing, plastic surgery, ophthalmology, tissue engineering these many classifications where the increase in use of biomaterials in cutting-edge cardiovascular devices is related to both the rising prevalence of cardiovascular illnesses and the two factors mentioned earlier. In terms of heart regeneration and repair, they show considerable promise. Among the other key application areas is the orthopedic sector. The prevalence of orthopedic replacements is predicted to increase during the forecast period, and novel biomaterials will also likely contribute to this trend.
[caption id="attachment_14497" align="aligncenter" width="1920"]
The Biomaterials Market key players include Koninklijke DSM N.V., Corbion N.V., EPTAM Plastics, Ltd., DiSanto Technology Inc., CoorsTek Medical LLC, Carpenter Technology Corporation, Zapp AG, United Titanium, Inc., Celanese Corporation, Victrex Plc, BASF SE, Evonik Industries AG
For corporate expansion, these key leaders are implementing strategic formulations such as new product development and commercialization, commercial expansion, and distribution agreements. Moreover, these participants are substantially spending on product development, which is fueling revenue generation.
March 2022, Evonik Industries commercially launched EUDRATEC Fasteric used for enteric fortification and prompt release in the upper smaller intestine, which is a platform of oral drug delivery technology directly over the released target. This product development improved the biocompatibility, safety, and performance of implantable products used by medical device customers and further strengthened Evonik’s growth.
September 2022, DSM announces a collaboration with PBC Biomed, a medical device design and development company to jointly design and develop novel materials for medical devices. Initially, the agreement will focus on the development of bone adhesives through PBC Biomed's affiliate, Biomimetic Innovations, which could help to meet the need for safer, less invasive surgical procedures that are also more cost-effective.
The Biomaterials Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
The market is dominant in region of North America the reason behind is attributed to soaring healthcare costs, growing public acceptance, and expanding awareness of implantable medical technology. Additionally, the region demand for biomaterials is being fueled by the existence of a sizable number of market participants, an increase in the need for implantable devices, and an increase in the number of knee and hip replacement surgeries. The regional industry is also being driven by women's growing interest in plastic surgery procedures like breast augmentation, facelifts, liposuction, and breast lifts.
A growing healthcare infrastructure, an increase in the prevalence of ophthalmic, neurological, cardiovascular, and orthopedic disorders, an increase in disposable incomes, the presence of well-established domestic companies, and an ageing population in the region all present lucrative opportunities for key players operating in the biomaterials market. As a result, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period.
[caption id="attachment_14498" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.